Literature DB >> 4417891

Urinary D-glucaric acid excretion and acetanilide pharmacokinetics before and during diphenylhydantoin administration.

J L Cunningham, D A Evans.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4417891     DOI： 10.1007/BF00558212

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  17 in total

1.  Clinical and electroencephalographic correlations with serum levels of diphenylhydanotin.

Authors:  F BUCHTHAL; O SVENSMARK; P J SCHILLER
Journal:  Arch Neurol       Date:  1960-06

2.  The estimation of acetanilide and its metabolic products, aniline, N-acetyl p-aminophenol and p-amino-phenol, free and total conjugated, in biological fluids and tissues.

Authors:  B B BRODIE; J AXELROD
Journal:  J Pharmacol Exp Ther       Date:  1948-09       Impact factor: 4.030

3.  Urinary D-glucaric-acid excretion as a test for hepatic enzyme induction in man.

Authors:  J Hunter; J D Maxwell; M Carrella; D A Stewart; R Williams
Journal:  Lancet       Date:  1971-03-20       Impact factor: 79.321

4.  Liver enzyme induction by anticonvulsant drugs, and its relationship to disturbed calcium and folic acid metabolism.

Authors:  A N Latham; L Millbank; A Richens; D J Rowe
Journal:  J Clin Pharmacol       Date:  1973 Aug-Sep       Impact factor: 3.126

5.  Effect of intensive occupational exposure to DDT on phenylbutazone and cortisol metabolism in human subjects.

Authors:  A Poland; D Smith; R Kuntzman; M Jacobson; A H Conney
Journal:  Clin Pharmacol Ther       Date:  1970 Sep-Oct       Impact factor: 6.875

6.  Clinical implications of enzyme induction.

Authors:  A Breckenridge; M Orme
Journal:  Ann N Y Acad Sci       Date:  1971-07-06       Impact factor: 5.691

7.  Plasma protein binding, plasma concentrations, and effects of diphenylhydantoin in man.

Authors:  L Lund; P K Lunde; A Rane; O Borga; F Sjöqvist
Journal:  Ann N Y Acad Sci       Date:  1971-07-06       Impact factor: 5.691

8.  Blood levels of drug at the equilibrium state after multiple dosing.

Authors:  J G Wagner; J I Northam; C D Alway; O S Carpenter
Journal:  Nature       Date:  1965-09-18       Impact factor: 49.962

9.  Osteomalacia with long-term anticonvulsant therapy in epilepsy.

Authors:  C E Dent; A Richens; D J Rowe; T C Stamp
Journal:  Br Med J       Date:  1970-10-10

10.  Stimulatory effect of N-phenylbarbital (phetharbital) on cortisol hydroxylation in man.

Authors:  R Kuntzman; M Jacobson; W Levin; A H Conney
Journal:  Biochem Pharmacol       Date:  1968-04       Impact factor: 5.858
View more
  12 in total

Review 1.  Pharmacokinetic drug interactions with phenytoin (Part II).

Authors:  R L Nation; A M Evans; R W Milne
Journal:  Clin Pharmacokinet       Date:  1990-02       Impact factor: 6.447

2.  Measurement of hepatic drug-metabolizing enxyme activity in man. Comparison of three different assays.

Authors:  E A Sotaniemi; R O Pelkonen; M Puukka
Journal:  Eur J Clin Pharmacol       Date:  1980-04       Impact factor: 2.953

3.  The interaction of chemical compounds with the functional state of the liver. II. Estimation of changes in D-glucaric acid synthesis as a method for diagnosing exposure to xenobiotics.

Authors:  W R Notten; P T Henderson
Journal:  Int Arch Occup Environ Health       Date:  1977       Impact factor: 3.015

4.  Effect of phenobarbitone on hepatic drug-metabolizing enzymes and urinary D-glucaric acid excretion in man.

Authors:  D S Lecamwasam; C Franklin; P Turner
Journal:  Br J Clin Pharmacol       Date:  1975-06       Impact factor: 4.335

5.  D-glucaric acid excretion in critical care patients--comparison with 6 beta-hydroxycortisol excretion and serum gamma-glutamyltranspeptidase activity and relation to multiple drug therapy.

Authors:  G Heinemeyer; I Roots; P Lestau; H R Klaiber; R Dennhardt
Journal:  Br J Clin Pharmacol       Date:  1986-01       Impact factor: 4.335

6.  Hepatic drug-oxidizing enzyme systems and urinary D-glucaric acid excretion in patients with congestive heart failure.

Authors:  O Tokola; O Pelkonen; N T Karki; P Luoma
Journal:  Br J Clin Pharmacol       Date:  1975-10       Impact factor: 4.335

Review 7.  Noninvasive assessment of microsomal enzyme activity in occupational medicine: present state of knowledge and future perspectives.

Authors:  M Døssing
Journal:  Int Arch Occup Environ Health       Date:  1984       Impact factor: 3.015

8.  Urinary excretion of D-glucaric acid, an indicator of drug metabolizing enzyme activity, in patients with impaired renal function.

Authors:  D Kampf; I Roots; A G Hildebrandt
Journal:  Eur J Clin Pharmacol       Date:  1980-10       Impact factor: 2.953

9.  Glucaric acid excretion. Analysis of the enzymatic assay and findings in smokers and non-smokers.

Authors:  K Fiedler; E Schröter; H Cramer
Journal:  Eur J Clin Pharmacol       Date:  1980-11       Impact factor: 2.953

10.  Antipyrine metabolite kinetics in healthy human volunteers during multiple dosing of phenytoin and carbamazepine.

Authors:  P N Shaw; J B Houston; M Rowland; K Hopkins; J F Thiercelin; P L Morselli
Journal:  Br J Clin Pharmacol       Date:  1985-12       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.